CPI-0610, bromodomain and extraterminal domain protein (BET) inhibitor, as "add-on" to ruxolitinib, in advanced myelofibrosis patients with suboptimal response: Update of MANIFEST phase 2 study Meeting Abstract
| Authors: | Somervaille, T.; Verstovsek, S.; Mascarenhas, J.; Kremyanskaya, M.; Hoffman, R.; Rampal, R.; Gupta, V.; Talpaz, M.; Granacher, N.; Leber, B.; Kiladjian, J. J.; Vannucchi, A.; Bose, P.; McMullin, M.; Sirhan, S.; Ribrag, V.; Prejzner, W.; Foltz, L.; Patriarca, A.; Lambert, J.; Luptakova, K.; Christo, J.; Wang, J.; Colak, G.; Shao, J.; Bobba, S.; Trojer, P.; Harrison, C. |
| Abstract Title: | CPI-0610, bromodomain and extraterminal domain protein (BET) inhibitor, as "add-on" to ruxolitinib, in advanced myelofibrosis patients with suboptimal response: Update of MANIFEST phase 2 study |
| Meeting Title: | 61st Annual Scientific Meeting of the British Society for Haematology |
| Journal Title: | British Journal of Haematology |
| Volume: | 193 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Apr 25-28 |
| Meeting Location: | Virtual |
| ISSN: | 0007-1048 |
| Publisher: | John Wiley & Sons |
| Date Published: | 2021-04-01 |
| Start Page: | 98 |
| End Page: | 99 |
| Language: | English |
| ACCESSION: | WOS:000645412200114 |
| PROVIDER: | wos |
| PUBMED: | 33928641 |
| DOI: | 10.1111/bjh.17492 |
| Notes: | Meeting Abstract: BSH2021-PO-070 -- Source: Wos |
